Review Articles
THE IMPORTANCE OF EPIGENETIC ALTERATIONS IN THE DEVELOPMENT OF EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
Abstract 701 | PDF Downloads 382 HTML Downloads 2811 | DOI https://doi.org/10.4084/mjhid.2009.012Page e2009012
EBV IN HODGKIN LYMPHOMA
Abstract 1220 | PDF Downloads 408 HTML Downloads 13753 | DOI https://doi.org/10.4084/mjhid.2009.013Page e2009013
EBV AND HIV-RELATED LYMPHOMA
Abstract 945 | PDF Downloads 469 HTML Downloads 6706 | DOI https://doi.org/10.4084/mjhid.2009.032Page e2009032
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
Abstract 918 | PDF Downloads 330 HTML Downloads 18459 Figure 1 Downloads 0 Figure 2 Downloads 0 Figure 3 Downloads 0 Figure 4 Downloads 0 Figure 5 Downloads 0 | DOI https://doi.org/10.4084/mjhid.2009.018Page e2009018
EPSTEIN-BARR VIRUS RELATED LYMPHOPROLIFERATIONS AFTER STEM CELL TRANSPLANTATION
Abstract 897 | PDF Downloads 397 HTML Downloads 2862 | DOI https://doi.org/10.4084/mjhid.2009.019Page e2009019
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
Abstract 874 | PDF Downloads 474 HTML Downloads 2989 | DOI https://doi.org/10.4084/mjhid.2009.030Page e2009030
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
Abstract 718 | PDF Downloads 430 HTML Downloads 6658 | DOI https://doi.org/10.4084/mjhid.2009.010Page e2009010
Original Articles
COMBINED MODALITY TREATMENT INCLUDING METHOTREXATE-BASED CHEMOTHERAPY FOR PRIMARY CEREBRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE
Abstract 1045 | PDF Downloads 402 HTML Downloads 2243 | DOI https://doi.org/10.4084/mjhid.2009.020Page e2009020